HAEMONETICS CORP Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Haemonetics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Haemonetics Corp Net Income (Loss) Attributable to Parent for the quarter ending June 29, 2024 was $38.4M, a 6.5% decline year-over-year.
  • Haemonetics Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 29, 2024 was $115M, a 15.9% decline year-over-year.
  • Haemonetics Corp annual Net Income (Loss) Attributable to Parent for 2023 was $118M, a 1.87% increase from 2022.
  • Haemonetics Corp annual Net Income (Loss) Attributable to Parent for 2022 was $115M, a 166% increase from 2021.
  • Haemonetics Corp annual Net Income (Loss) Attributable to Parent for 2021 was $43.4M, a 45.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $115M $38.4M -$2.67M -6.5% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $118M $20.4M -$9.02M -30.7% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 $127M $31.2M -$1.7M -5.17% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $128M $24.9M -$8.29M -25% Jul 2, 2023 Sep 30, 2023 10-Q 2024-02-08
Q2 2023 $137M $41M +$21.2M +106% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 $115M $29.4M +$19.6M +202% Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 $95.8M $32.9M +$9.71M +41.8% Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $86M $33.2M +$18.3M +123% Jul 3, 2022 Oct 1, 2022 10-Q 2024-02-08
Q2 2022 $67.7M $19.9M +$24.3M Apr 3, 2022 Jul 2, 2022 10-Q 2024-02-08
Q1 2022 $43.4M $9.74M +$20.8M Jan 2, 2022 Apr 2, 2022 10-K 2024-05-20
Q4 2021 $22.6M $23.2M -$8.65M -27.1% Oct 3, 2021 Jan 1, 2022 10-Q 2023-02-07
Q3 2021 $31.2M $14.9M -$33.2M -69.1% Jul 4, 2021 Oct 2, 2021 10-Q 2023-02-07
Q2 2021 $64.5M -$4.45M -$15M -142% Apr 4, 2021 Jul 3, 2021 10-Q 2023-02-07
Q1 2021 $79.5M -$11M -$28.7M -163% Dec 27, 2020 Apr 3, 2021 10-K 2021-05-26
Q4 2020 $108M $31.9M +$1.99M +6.65% Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 $106M $48.1M +$10.6M +28.3% Jun 28, 2020 Sep 26, 2020 10-Q 2022-02-08
Q2 2020 $95.5M $10.5M +$19M Mar 29, 2020 Jun 27, 2020 10-Q 2022-02-08
Q1 2020 $76.5M $17.6M -$3.21M -15.4% Dec 29, 2019 Mar 28, 2020 10-K 2021-05-26
Q4 2019 $79.7M $29.9M +$38.4M Sep 29, 2019 Dec 28, 2019 10-K 2021-05-26
Q3 2019 $41.4M $37.5M +$18.8M +100% Jun 30, 2019 Sep 28, 2019 10-K 2021-05-26
Q2 2019 $22.6M -$8.48M -$5.66M -201% Mar 31, 2019 Jun 29, 2019 10-K 2021-05-26
Q1 2019 $28.3M $20.8M +$8.96M +75.4% Dec 30, 2018 Mar 30, 2019 10-K 2020-05-20
Q4 2018 $19.3M -$8.48M -$1.93M -29.5% Sep 30, 2018 Dec 29, 2018 10-Q 2020-08-04
Q3 2018 $21.2M $18.7M -$1.38M -6.85% Jul 1, 2018 Sep 29, 2018 10-K 2020-05-20
Q2 2018 $22.6M -$2.82M -$23M -114% Apr 1, 2018 Jun 30, 2018 10-K 2020-05-20
Q1 2018 $45.6M $11.9M +$63M Dec 31, 2017 Mar 31, 2018 10-K 2019-05-22
Q4 2017 -$17.4M -$6.55M -$21.9M -143% Oct 1, 2017 Dec 30, 2017 10-K 2019-05-22
Q3 2017 $4.49M $20.1M +$277K +1.4% Jul 2, 2017 Sep 30, 2017 10-K 2019-05-22
Q2 2017 $4.22M $20.1M +$30.5M Apr 2, 2017 Jul 1, 2017 10-K 2019-05-22
Q1 2017 -$26.3M -$51.1M -$42.4M -485% Jan 1, 2017 Apr 1, 2017 10-K 2018-05-23
Q4 2016 $16.1M $15.4M +$74.8M Oct 2, 2016 Dec 31, 2016 10-K 2018-05-23
Q3 2016 -$58.7M $19.8M +$6.96M +54.1% Jul 3, 2016 Oct 1, 2016 10-K 2018-05-23
Q2 2016 -$65.7M -$10.3M -$10.1M -3775% Apr 3, 2016 Jul 2, 2016 10-K 2018-05-23
Q1 2016 -$55.6M -$8.74M -$5.81M -198% Dec 27, 2015 Apr 2, 2016 10-K 2017-05-24
Q4 2015 -$49.8M -$59.4M -$75.4M -472% Sep 27, 2015 Dec 26, 2015 10-K 2017-05-24
Q3 2015 $25.7M $12.9M +$5.38M +71.8% Jun 28, 2015 Sep 26, 2015 10-K 2017-05-24
Q2 2015 $20.3M -$267K +$3.38M +92.7% Mar 29, 2015 Jun 27, 2015 10-K 2017-05-24
Q1 2015 $16.9M -$2.93M -$13.1M -129% Dec 28, 2014 Mar 28, 2015 10-K 2016-06-01
Q4 2014 $30M $16M -$302K -1.85% Sep 28, 2014 Dec 27, 2014 10-K 2016-06-01
Q3 2014 $30.3M $7.49M -$9.06M -54.8% Jun 29, 2014 Sep 27, 2014 10-K 2016-06-01
Q2 2014 $39.4M -$3.65M +$4.23M +53.7% Mar 30, 2014 Jun 28, 2014 10-K 2016-06-01
Q1 2014 $35.1M $10.2M -$2.38M -18.9% Dec 29, 2013 Mar 29, 2014 10-K 2015-05-22
Q4 2013 $37.5M $16.3M +$6.39M +64.5% Sep 29, 2013 Dec 28, 2013 10-K 2015-05-22
Q3 2013 $31.1M $16.5M +$10M +153% Jun 30, 2013 Sep 28, 2013 10-K 2015-05-22
Q2 2013 $21.1M -$7.87M -$17.7M -180% Mar 31, 2013 Jun 29, 2013 10-K 2015-05-22
Q1 2013 $38.8M $12.6M -$5.24M -29.4% Dec 30, 2012 Mar 30, 2013 10-K 2014-05-22
Q4 2012 $44M $9.9M -$8.35M -45.7% Sep 30, 2012 Dec 29, 2012 10-K 2014-05-22
Q3 2012 $52.4M $6.55M -$7.33M -52.8% Jul 1, 2012 Sep 29, 2012 10-K 2014-05-22
Q2 2012 $59.7M $9.79M -$7.16M -42.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-05-22
Q1 2012 $66.9M $17.8M -$3.18M -15.2% Jan 1, 2012 Mar 31, 2012 10-K 2013-05-20
Q4 2011 $70.1M $18.3M -$1.48M -7.5% Oct 2, 2011 Dec 31, 2011 10-K 2013-05-20
Q3 2011 $71.6M $13.9M -$7.46M -35% Jul 3, 2011 Oct 1, 2011 10-K 2013-05-20
Q2 2011 $79M $16.9M -$971K -5.42% Apr 3, 2011 Jul 2, 2011 10-K 2013-05-20
Q1 2011 $80M $21M Jan 2, 2011 Apr 2, 2011 10-K 2012-05-22
Q4 2010 $19.7M Oct 3, 2010 Jan 1, 2011 10-K 2012-05-22
Q3 2010 $21.3M Jul 4, 2010 Oct 2, 2010 10-K 2012-05-22
Q2 2010 $17.9M Apr 4, 2010 Jul 3, 2010 10-K 2012-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.